Castrate-Resistant Prostate Cancer Market Demand, Treatment Trends and Industry Insights
Valued at USD 12.92 billion in 2024, the Castrate-Resistant Prostate Cancer Market is projected to reach USD 14.04 billion in 2025 and USD 29.79 billion by 2034, growing at a CAGR of 8.7% during the forecast period 2025–2034. Expansion reflects more diagnoses of advanced prostate cancer, improved awareness and early detection, and new developments in treatment that help patients live...
0 Комментарии 0 Поделились 69 Просмотры 0 предпросмотр